Clinical Trials Browser

Phase 3 × Imiquimod × Other neoplasm × Clear all

NCT00175643 2006-05-09

Safety and Efficacy of Imiquimod Applied in Dose-Cycle for Actinic Keratoses

Phase 3 Completed

DermatologicOther neoplasm

Carcinoma, Squamous Cell, Precancerous Conditions, Keratosis, Actinic